AU1915201A - Improving stability of flint through o-linked glycosylation - Google Patents

Improving stability of flint through o-linked glycosylation

Info

Publication number
AU1915201A
AU1915201A AU19152/01A AU1915201A AU1915201A AU 1915201 A AU1915201 A AU 1915201A AU 19152/01 A AU19152/01 A AU 19152/01A AU 1915201 A AU1915201 A AU 1915201A AU 1915201 A AU1915201 A AU 1915201A
Authority
AU
Australia
Prior art keywords
flint
linked glycosylation
improving stability
stability
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19152/01A
Inventor
Jirong Lu
Derrick Ryan Witcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1915201A publication Critical patent/AU1915201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU19152/01A 1999-12-07 2000-11-29 Improving stability of flint through o-linked glycosylation Abandoned AU1915201A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US16936799P 1999-12-07 1999-12-07
US16941299P 1999-12-07 1999-12-07
US16938199P 1999-12-07 1999-12-07
US60169381 1999-12-07
US60169412 1999-12-07
US60169367 1999-12-07
US19143000P 2000-03-23 2000-03-23
US60191430 2000-03-23
PCT/US2000/030166 WO2001042463A1 (en) 1999-12-07 2000-11-29 Improving stability of flint through o-linked glycosylation

Publications (1)

Publication Number Publication Date
AU1915201A true AU1915201A (en) 2001-06-18

Family

ID=27496833

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19152/01A Abandoned AU1915201A (en) 1999-12-07 2000-11-29 Improving stability of flint through o-linked glycosylation

Country Status (3)

Country Link
EP (1) EP1244783A1 (en)
AU (1) AU1915201A (en)
WO (1) WO2001042463A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
EP1007659B1 (en) 1997-01-14 2007-06-27 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6 alpha & 6 beta
EP1336619A3 (en) * 2002-02-19 2003-12-10 Millenium Pharmaceuticals, Inc. Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders
WO2009039310A2 (en) 2007-09-18 2009-03-26 La Jolla Institute For Allergy And Immunology Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134578A0 (en) * 1997-09-18 2001-04-30 Genentech Inc DcR3 POLYPEPTIDE, A TNFR HOMOLOG
PL343847A1 (en) * 1998-03-30 2001-09-10 Lilly Co Eli Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
CN1345329A (en) * 1999-03-04 2002-04-17 人体基因组科学有限公司 Tumor mecrosis factor receptors 6 alpha and beta
AU2495200A (en) * 1999-03-08 2000-09-28 Genentech Inc. Compositions and methods for the treatment of tumor
AU3739400A (en) * 1999-03-30 2000-10-16 Eli Lilly And Company Flint polypeptide analogs

Also Published As

Publication number Publication date
EP1244783A1 (en) 2002-10-02
WO2001042463A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
AU4943200A (en) Modified cytokine
AU5913500A (en) Mattress assembly
AU1269601A (en) Fungamyl-like alpha-amylase variants
AU2705201A (en) Ceramic structure
AU5678201A (en) Electrode structure of ec mirror
AU5470199A (en) Disintegratable microspheres
AU2522399A (en) Tea manufacture
AU3388400A (en) Human glycosylation enzymes
AUPP967999A0 (en) Viral variants
AU5165700A (en) Terminal design
EG22530A (en) Preparation of substituted piperidin-4-ones
GB2350360B (en) Short flint special glasses
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU3739400A (en) Flint polypeptide analogs
AU3248000A (en) Manufacture of polyketones
AU1915201A (en) Improving stability of flint through o-linked glycosylation
AU2201501A (en) Structure
AU5508999A (en) Mounting structure
TW435837U (en) Structure improvement of connector
AU1870601A (en) Refractory insulating construction element
AU3829900A (en) Preparation of norlabdane oxide
AU5298100A (en) Preparation of enantio-specific epoxides
TW426245U (en) Screwed position structure of connecting seat terminal
TW435842U (en) Assembled structure of connector
AU5103100A (en) Novel cytokine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase